Background Atopic dermatitis (AD, eczema) is driven by a combination of skin barrier
defects, immune dysregulation, and extrinsic stimuli such as allergens, irritants, and …

Abstract Peanut allergy affects about 1%–3% of the pediatric population in the world, with an
important increase in the last decades. Nowadays, international guidelines recommend the …

Background Sensitization to house dust mites (HDMs) is frequent in patients with atopic
dermatitis. Objective To investigate the efficacy of sublingual immunotherapy (SLIT) with …

Background Guidance addressing atopic dermatitis (AD) management, last issued in 2012
by the American Academy of Allergy, Asthma and Immunology/American College of Allergy …

Although currently approved to treat severe asthma and chronic spontaneous urticaria,
omalizumab has also been an effective and safe add-on treatment for other allergic …

Allergic respiratory diseases, such as asthma and allergic rhinitis, are global health issues
and have had an increasing prevalence in the last decades. Allergen‐specific …

The incidence of immune-mediated diseases (IMDs) is increasing rapidly in the developed
countries constituting a huge medical, economic, and societal challenge. The exposome …

Skin inflammation, known as atopic dermatitis (AD), is often accompanied by various
psychological disorders. The objective of this meta-analysis was to assess the impact of AD …

Background. Atopic dermatitis (AD) is a complex, chronic, inflammatory skin disease
characterized by pruritic, intense itching, and eczematous lesions affecting about 25% of …

Background: Severe atopic dermatitis (AD) is a complex disease requiring systemic
treatment. This study aimed to assess the effectiveness of combined therapy consisting of …